The role of kinin B 1 and B 2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice

British Journal of Pharmacology

Volumn 159, Issue 4, 2010, Pages 888-897

  Costa, Robson ^a   Manjavachi, Marianne N ^a   Motta, Emerson M ^a   Marotta, Denise M ^a   Juliano, Luiz ^b   Torres, Hugo A ^b   Pesquero, João B ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Kinin B 2 and B 1 receptors; Kinins; PAR 2; Scratching behaviour

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; G PROTEIN COUPLED RECEPTOR; ICATIBANT; KININ B1 RECEPTOR; KININ B1 RECEPTOR ANTAGONIST; KININ B2 RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; RECEPTOR BLOCKING AGENT; SSR 240612; TRYPSIN; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; 2 ((3 (1,3 BENZODIOXOL 5 YL) 3 (((6 METHOXY 2 NAPHTHYL)SULFONYL)AMINO)PROPANOYL)AMINO) 3 (4 ((2,6 DIMETHYLPIPERIDINYL)METHYL)PHENYL) N ISOPROPYL N METHYLPROPANAMIDE; 2-((3-(1,3-BENZODIOXOL-5-YL)-3-(((6-METHOXY-2-NAPHTHYL)SULFONYL)AMINO)PROPANOYL)AMINO)-3-(4-((2,6-DIMETHYLPIPERIDINYL)METHYL)PHENYL)-N-ISOPROPYL-N-METHYLPROPANAMIDE; ANTIPRURITIC AGENT; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ, LEU(8) DES ARG(9); BRADYKININ, LEU(8)-DES-ARG(9)-; DRUG DERIVATIVE; OLIGOPEPTIDE; QUINOLINE DERIVATIVE; SERYL LEUCYL ISOLEUCYL GLYCYL ARGINYL LEUCINAMIDE; SERYL-LEUCYL-ISOLEUCYL-GLYCYL--ARGINYL-LEUCINAMIDE; SULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PAIN THRESHOLD; PRURITUS; PSYCHOLOGICAL ASPECT;

ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; BRADYKININ; DIOXOLES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGOPEPTIDES; PAIN THRESHOLD; PRURITUS; QUINOLINES; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTOR, PAR-2; SULFONAMIDES; TRYPSIN;

EID: 77249127493     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00571.x     Document Type: Article

References (53)

1. Akiyama T, Merrill AW, Carstens MI, Carstens E (2009). Activation of superficial dorsal horn neurons in the mouse by a PAR-2 agonist and 5-HT: potential role in itch. J Neurosci 29 : 6691 6699.
2. Alexander SPH, Mathie A, Peters JA (2007). Guide to receptors and channels (GRAC), 2nd Edition (2007 revision). Br J Pharmacol 150 (Suppl. 1 S1 S168.
3. 2 bradykinin receptor knockout mice. Immunopharmacology 33 : 333 335. (Pubitemid 26247961)
4. Calixto JB, Cabrini DA, Ferreira J, Campos MM (2000). Kinins in pain and inflammation. Pain 87 : 1 5.
5. Calixto JB, Cabrini DA, Ferreira J, Campos MM (2001). Inflamatory pain: kinins and antagonists. Cur Op Anesthesiol 14 : 519 526.
6. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM (2004). Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143 : 803 818.
7. Campos MM, Mata LV, Calixto JB (1995). Expression of B1 kinin receptors mediating paw edema and formalin-induced nociception. Modulation by glucocorticoids. Can J Physiol Pharmacol. 73 : 812 819.
8. 1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 27 : 646 651.
9. 2 receptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 360 : 278 286.
10. Chapman V, Dickenson AH (1992). The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol 219 : 427 433.
11. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110 : 193 198.
12. Corvera CU, Dery O, Mcconalogue K, Bohm SK, Khitin LM, Caughey GH et al. (1997). Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 100 : 1383 1393.
13. Costa R, Fernandes ES, Menezes-De-Lima O Jr., Campos MM, Calixto JB (2006). Effect of novel selective non-peptide kinin B(1) receptor antagonists on mouse pleurisy induced by carrageenan. Peptides 27 : 2967 2975.
14. Costa R, Marotta DM, Manjavachi MN, Fernandes ES, Lima-Garcia JF, Paszcuk AF et al. (2008). Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol 154 : 1094 1103.
15. Cottrell GS, Amadesi S, Grady EF, Bunnett NW (2004). Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 279 : 13532 13539.
16. De Campos RO, Henriques MG, Calixto JB (1998). Systemic treatment with Mycobacterium bovis bacillus Calmette-Guerin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice. Neuropeptides 32 : 393 403.
17. 1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology 43 : 1188 1197.
18. Ferreira J, Da Silva GL, Calixto JB (2004). Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 141 : 787 794.
19. 1 receptors in the nociception produced by peripheral protein kinase C activation in mice. Neuropharmacology 54 : 597 604.
20. 1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104 : 683 691.
21. Ganju P, Davis A, Patel S, Nunez X, Fox A (2001). p38 stress-activated protein kinase inhibitor reverses bradykinin B(1) receptor-mediated component of inflammatory hyperalgesia. Eur J Pharmacol 421 : 191 199.
22. 2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Br J Pharmacol 124 : 1328 1334.
23. 2 receptor antagonists. Br J Pharmacol 126 : 197 204.
24. Hosogi M, Schmelz M, Miyachi Y, Ikoma A (2006). Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain 126 : 16 23.
25. Hylden JL, Wilcox GL (1980). Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67 : 313 316.
26. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M (2006). The neurobiology of itch. Nat Rev Neurosci 7 : 535 547.
27. Kawabata A, Kawao N, Kitano T, Matsunami M, Satoh R, Ishiki T et al. (2006). Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin. Neurosci Lett 402 : 167 172.
28. Laursen SE, Belknap JK (1986). Intracerebroventricular injections in mice: some methodological refinements. J Pharmacol Methods 16 : 355 357.
29. Ma QP (2001). The expression of bradykinin B1 receptors on primary sensory neurones that give rise to small calibre sciatic nerve fibres in rats. Neuroscience 107 : 665 673.
30. Ma QP, Heavens R (2000). Basal expression of bradykinin B(1) receptor in the spinal cord in humans and rats. Neuroreport 12 : 2311 2314.
31. Marceau F, Regoli D (2004). Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3 : 845 852.
32. Paszcuk AF, Quintão NLM, Fernandes ES, Juliano L, Chapman K, Andrade-Gordon P et al. (2008). Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol. 581 : 204 215.
33. Paus R, Schmelz M, Biro T, Steinhoff M (2006). Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116 : 1174 1186.
34. Perkins MN, Kelly D (1994). Interleukin-1b induced-desArg9-bradykinin- mediated thermal hyperalgesia in the rat. Neuropharmacology 33 : 657 660.
35. 1 receptors. Proc Natl Acad Sci USA 97 : 8140 8145.
36. Pietrovski EF, Otuki MF, Regoli D, Bader M, Pesquero JB, Cabrini DA et al. (2009). The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation. Regul Pept 152 : 67 72.
37. 2 receptors. J Neurosci 28 : 2856 2863.
38. Rajakulasingam K, Polosa R, Holgate ST, Howarth PH (1991). Comparative nasal effects of bradykinin, kallidin and Des-Arg9-bradykinin in atopic rhinitic and normal volunteers. J Physiol 437 : 577 587.
39. Ramachandran R, Hollenberg MD (2008). Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 (Suppl. 1 S263 S282.
40. 2 receptor on nociception in rats and mice. Pain 71 : 89 97.
41. Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjork HE, Handwerker HO (2003). Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 89 : 2441 2448.
42. Shimada SG, Shimada KA, Collins JG (2006). Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2. Eur J Pharmacol 530 : 281 283.
43. Steinhoff M, Corvera CU, Thoma MS, Kong W, Mcalpine BE, Caughey GH et al. (1999). Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8 : 282 294.
44. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS et al. (2003). Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23 : 6176 6180.
45. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T (2006). Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 126 : 1705 1718.
46. Sun YG, Chen ZF (2007). A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448 : 700 703.
47. Tsujii K, Andoh T, Lee JB, Kuraishi Y (2008). Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. J Pharmacol Sci 108 : 385 388.
48. Tsujii K, Andoh T, Ui1 H, Lee JB, Kuraishi Y (2009). Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis. J Pharmacol Sci 109 : 388 395.
49. Ui H, Andoh T, Lee JB, Nojima H, Kuraishi Y (2006). Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530 : 172 178.
50. Vergnolle N (2009). Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 123 : 292 309.
51. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD (2001). Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22 : 146 152.
52. Vergnolle N, Ferazzini M, D'andrea MR, Buddenkotte J, Steinhoff M (2003). Proteinase-activated receptors: novel signals for peripheral nerves. Trends Neurosci 26 : 496 500.
53. Wothersponn G, Winter J (2000). Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci Lett 294 : 175 178.